Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

A polymorphism in MAPKAPK3 affects response to interferon therapy for chronic hepatitis C.

Tsukada H, Ochi H, Maekawa T, Abe H, Fujimoto Y, Tsuge M, Takahashi H, Kumada H, Kamatani N, Nakamura Y, Chayama K. A polymorphism in MAPKAPK3 affects response to interferon therapy for chronic hepatitis C. Gastroenterology. 2009 May; 136(5):1796-805.e6.

View in: PubMed

collapse authors with profiles